Remove ucb-finally-gets-win-fda-scoring-approval-myasthenia-gravis-drug-rystiggo
article thumbnail

UCB finally gets a win with the FDA, scoring approval for myasthenia gravis drug Rystiggo

Fierce Pharma

This has been a second straight year of regulatory struggles in the United States for UCB with one of the those issues revolving around the FDA needing additional time to

FDA 259